SCHEMBL332226

SCHEMBL332226

CC(=O)c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.66
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HPGD P15428 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
RARB P10826 1/20 0.36
RARG P13631 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HDAC1 Q13547 1/20 0.34
PIK3CD O00329 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654887 0.86 ALOX5 (0.68) ALOX5ALDH1A1LMNAL3MBTL1HRH3
SCHEMBL332843 0.85 ALOX5 (0.52) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL333261 0.84 ALOX5 (0.58) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL333086 0.82 ALOX5 (0.61) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL9049501 0.81 HPGD (0.47) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL13201380 0.81 ALOX5 (0.58) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL8173632 0.80 ALOX5 (0.67) ALOX5NPC1MAPTCYP2C9CYP2C19
SCHEMBL8166180 0.80 ALOX5 (0.67) ALOX5ALDH1A1LMNAHRH3PIK3CD
Pf-4191834 SCHEMBL29369341 0.80 ALOX5 (0.81) ALOX5HRH3PIK3CD
Pf-4191834 SCHEMBL332973 0.80 ALOX5 (0.81) ALOX5HRH3PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 US disclosed
EP-2225229-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS Pfizer Inc. (US) 2010-09-08 EP disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 US disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors ALOX5, ALOX15, CYP3A5 ALOX5 1/4885NPC1 1623/4885MAPT 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.